| 2.3 |
6.8 |
GO:1904036 |
negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 2.2 |
6.7 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 2.1 |
2.1 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
| 1.7 |
6.9 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.5 |
6.1 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 1.5 |
4.5 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 1.4 |
1.4 |
GO:0051168 |
nuclear export(GO:0051168) |
| 1.4 |
6.9 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 1.3 |
4.0 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 1.3 |
3.8 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 1.2 |
1.2 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 1.2 |
3.5 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 1.2 |
4.7 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 1.1 |
4.4 |
GO:0071025 |
RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 1.1 |
4.4 |
GO:0010900 |
regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.1 |
2.2 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 1.1 |
5.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.0 |
9.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 1.0 |
4.2 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 1.0 |
3.8 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.9 |
2.8 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.9 |
2.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.9 |
3.7 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.9 |
4.5 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.9 |
2.7 |
GO:0050983 |
spermidine catabolic process(GO:0046203) deoxyhypusine biosynthetic process from spermidine(GO:0050983) |
| 0.9 |
3.5 |
GO:0009221 |
pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
| 0.9 |
2.6 |
GO:0018283 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.8 |
2.5 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.8 |
3.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.8 |
2.5 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.8 |
3.3 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.8 |
7.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.8 |
2.4 |
GO:0060295 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.8 |
3.2 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.8 |
2.3 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.8 |
1.6 |
GO:0001832 |
blastocyst growth(GO:0001832) |
| 0.8 |
0.8 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.8 |
3.9 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.8 |
29.9 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.7 |
4.5 |
GO:0009304 |
tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.7 |
2.9 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.7 |
4.3 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.7 |
2.9 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.7 |
2.8 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.7 |
11.8 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.7 |
2.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.7 |
2.8 |
GO:0090267 |
positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.7 |
2.7 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) snRNA transport(GO:0051030) |
| 0.7 |
2.7 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.7 |
5.3 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.7 |
5.3 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.7 |
9.2 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.7 |
2.0 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.6 |
7.1 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.6 |
1.9 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.6 |
1.9 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.6 |
2.5 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.6 |
1.2 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.6 |
1.9 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.6 |
20.4 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.6 |
4.8 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.6 |
2.4 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.6 |
1.7 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.6 |
11.7 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.6 |
1.1 |
GO:0060263 |
regulation of hydrogen peroxide metabolic process(GO:0010310) regulation of respiratory burst(GO:0060263) |
| 0.5 |
5.9 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.5 |
2.7 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.5 |
1.6 |
GO:0097237 |
cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 0.5 |
0.5 |
GO:0002418 |
immune response to tumor cell(GO:0002418) |
| 0.5 |
6.4 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.5 |
2.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.5 |
2.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.5 |
2.1 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.5 |
1.5 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.5 |
3.1 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.5 |
2.0 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.5 |
2.0 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.5 |
1.5 |
GO:0010041 |
response to iron(III) ion(GO:0010041) positive regulation of histone phosphorylation(GO:0033129) response to DDT(GO:0046680) regulation of chromosome condensation(GO:0060623) cellular response to iron ion(GO:0071281) cellular response to iron(III) ion(GO:0071283) |
| 0.5 |
2.0 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.5 |
0.5 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.5 |
1.9 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.5 |
15.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.5 |
4.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.5 |
8.0 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.5 |
0.9 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
| 0.5 |
1.8 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
| 0.4 |
1.3 |
GO:0070445 |
Fc receptor mediated stimulatory signaling pathway(GO:0002431) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.4 |
1.3 |
GO:0006188 |
IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
| 0.4 |
4.0 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.4 |
3.1 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.4 |
0.9 |
GO:0036260 |
7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.4 |
0.9 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.4 |
2.1 |
GO:0006310 |
DNA recombination(GO:0006310) |
| 0.4 |
1.7 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.4 |
1.7 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.4 |
1.7 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.4 |
2.1 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.4 |
1.2 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.4 |
2.8 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.4 |
4.0 |
GO:1901985 |
positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.4 |
1.6 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.4 |
1.2 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.4 |
4.8 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.4 |
3.9 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.4 |
10.3 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.4 |
6.2 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.4 |
1.2 |
GO:0046080 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) dUTP metabolic process(GO:0046080) |
| 0.4 |
3.5 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.4 |
1.1 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.4 |
1.9 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.4 |
2.3 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.4 |
1.9 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.4 |
6.0 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.4 |
1.1 |
GO:1990170 |
detoxification of cadmium ion(GO:0071585) stress response to cadmium ion(GO:1990170) |
| 0.4 |
2.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.4 |
4.4 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.4 |
2.6 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.4 |
1.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.4 |
1.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.4 |
3.6 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.4 |
1.4 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.4 |
0.4 |
GO:0002313 |
mature B cell differentiation involved in immune response(GO:0002313) |
| 0.4 |
2.5 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.3 |
0.3 |
GO:0001974 |
blood vessel remodeling(GO:0001974) |
| 0.3 |
1.0 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) maturation of SSU-rRNA(GO:0030490) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.3 |
1.0 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.3 |
3.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.3 |
2.0 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.3 |
0.3 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.3 |
1.7 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 |
1.7 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 |
2.6 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.3 |
1.0 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.3 |
3.0 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.3 |
1.6 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.3 |
0.3 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 |
1.0 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.3 |
0.3 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.3 |
1.9 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
1.9 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.3 |
1.0 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.3 |
0.3 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
12.1 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.3 |
0.3 |
GO:0071312 |
cellular response to alkaloid(GO:0071312) |
| 0.3 |
2.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.3 |
2.5 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.3 |
1.6 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.3 |
5.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.3 |
0.6 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
1.5 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.3 |
0.3 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.3 |
0.6 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.3 |
0.3 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.3 |
0.3 |
GO:0010993 |
ubiquitin homeostasis(GO:0010992) regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.3 |
4.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.3 |
0.9 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.3 |
13.4 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.3 |
12.5 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.3 |
0.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.3 |
4.7 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.3 |
1.5 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 |
21.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.3 |
0.3 |
GO:0008016 |
regulation of heart contraction(GO:0008016) |
| 0.3 |
0.9 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 |
1.2 |
GO:0000959 |
mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
| 0.3 |
1.4 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 |
0.9 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.3 |
0.3 |
GO:0034504 |
protein localization to nucleus(GO:0034504) |
| 0.3 |
10.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
1.1 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.3 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.3 |
0.3 |
GO:0097300 |
necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
| 0.3 |
1.1 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.3 |
1.6 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.3 |
1.4 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.3 |
3.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.3 |
10.3 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.3 |
3.5 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.3 |
9.1 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.3 |
0.8 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 |
1.0 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 |
0.3 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.3 |
0.3 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.3 |
0.8 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 |
0.7 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.2 |
1.0 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
2.0 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
0.5 |
GO:0045444 |
fat cell differentiation(GO:0045444) |
| 0.2 |
0.7 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.2 |
1.7 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.2 |
1.7 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.2 |
1.9 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.7 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.2 |
0.5 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.2 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.2 |
2.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.2 |
0.2 |
GO:2000078 |
regulation of type B pancreatic cell development(GO:2000074) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.2 |
0.7 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 |
1.4 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 |
0.5 |
GO:0043065 |
positive regulation of apoptotic process(GO:0043065) |
| 0.2 |
0.2 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 |
2.8 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.2 |
0.5 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
12.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
2.7 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.2 |
2.0 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.2 |
0.7 |
GO:0015854 |
guanine transport(GO:0015854) hypoxanthine transport(GO:0035344) thymine transport(GO:0035364) |
| 0.2 |
0.7 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.2 |
0.7 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
| 0.2 |
2.2 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.2 |
0.7 |
GO:0000917 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
| 0.2 |
12.9 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.2 |
0.7 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.2 |
1.3 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.2 |
2.6 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.2 |
1.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
20.0 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.2 |
5.3 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.2 |
0.6 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.2 |
0.6 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 |
1.0 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.2 |
1.9 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.2 |
0.8 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.2 |
0.6 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.2 |
2.5 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.2 |
1.8 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.2 |
0.2 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.2 |
0.8 |
GO:0001807 |
type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.2 |
0.8 |
GO:2001259 |
positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
| 0.2 |
1.6 |
GO:0060123 |
regulation of growth hormone secretion(GO:0060123) |
| 0.2 |
1.4 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 |
0.8 |
GO:0071436 |
sodium ion export(GO:0071436) |
| 0.2 |
0.6 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.2 |
1.2 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.2 |
1.0 |
GO:0051323 |
metaphase(GO:0051323) |
| 0.2 |
1.0 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
1.0 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.2 |
4.7 |
GO:0006396 |
RNA processing(GO:0006396) |
| 0.2 |
2.5 |
GO:0006111 |
regulation of gluconeogenesis(GO:0006111) |
| 0.2 |
0.6 |
GO:0032196 |
transposition, DNA-mediated(GO:0006313) transposition(GO:0032196) |
| 0.2 |
0.8 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
6.3 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 |
0.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
4.7 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.2 |
0.4 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
3.9 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.2 |
1.9 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.2 |
1.5 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
3.7 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.2 |
1.3 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.2 |
5.5 |
GO:0045839 |
negative regulation of mitotic nuclear division(GO:0045839) |
| 0.2 |
1.1 |
GO:0043316 |
natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.2 |
0.7 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.9 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.2 |
0.7 |
GO:0009636 |
response to toxic substance(GO:0009636) |
| 0.2 |
0.5 |
GO:0046604 |
regulation of mitotic centrosome separation(GO:0046602) positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 |
1.1 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
1.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
0.9 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 |
0.7 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.2 |
0.2 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
| 0.2 |
0.5 |
GO:0072677 |
eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.2 |
1.6 |
GO:0070189 |
kynurenine metabolic process(GO:0070189) |
| 0.2 |
0.3 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.2 |
5.5 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.2 |
0.2 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.2 |
1.4 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.2 |
7.0 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.2 |
1.2 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.2 |
1.2 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.2 |
2.2 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 |
0.8 |
GO:0051961 |
negative regulation of nervous system development(GO:0051961) |
| 0.2 |
0.5 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.2 |
6.9 |
GO:0000236 |
mitotic prometaphase(GO:0000236) |
| 0.2 |
1.8 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.2 |
2.2 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.2 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
3.1 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.2 |
14.3 |
GO:0000216 |
obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
| 0.2 |
0.7 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
0.8 |
GO:0002456 |
T cell mediated immunity(GO:0002456) |
| 0.2 |
0.7 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.2 |
0.8 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.2 |
7.2 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.2 |
0.7 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
| 0.2 |
0.3 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.2 |
16.9 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.2 |
0.5 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 0.2 |
21.8 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.2 |
6.6 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.2 |
3.2 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.2 |
2.6 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.2 |
0.6 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.2 |
1.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.2 |
1.1 |
GO:0075713 |
establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
| 0.2 |
3.7 |
GO:0051181 |
cofactor transport(GO:0051181) |
| 0.2 |
1.5 |
GO:0006839 |
mitochondrial transport(GO:0006839) |
| 0.2 |
0.3 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.2 |
1.5 |
GO:0010827 |
regulation of glucose transport(GO:0010827) |
| 0.2 |
0.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
2.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
1.3 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.1 |
0.6 |
GO:0034723 |
DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
3.3 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 |
1.5 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.6 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.1 |
0.9 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.1 |
0.6 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.6 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.1 |
1.1 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 |
0.1 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) |
| 0.1 |
1.0 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
1.8 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
0.1 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.1 |
0.7 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.1 |
0.6 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.7 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.7 |
GO:0010957 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.1 |
3.0 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
1.8 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
0.7 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
1.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.3 |
GO:0032652 |
regulation of interleukin-1 production(GO:0032652) |
| 0.1 |
0.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.4 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 |
4.0 |
GO:0031023 |
microtubule organizing center organization(GO:0031023) |
| 0.1 |
0.3 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.1 |
0.4 |
GO:0071107 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) response to parathyroid hormone(GO:0071107) |
| 0.1 |
0.3 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.1 |
0.8 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.1 |
0.4 |
GO:0046368 |
GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.6 |
GO:0090178 |
establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
0.8 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.3 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
2.7 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
14.0 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.1 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
1.0 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
3.1 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
0.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
2.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.7 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 |
0.5 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
1.2 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 |
0.2 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 |
7.8 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
0.6 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.1 |
1.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.4 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 |
0.4 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.1 |
0.2 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.1 |
0.5 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.8 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
5.0 |
GO:0006302 |
double-strand break repair(GO:0006302) |
| 0.1 |
0.4 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.5 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
0.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
3.7 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.1 |
0.6 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) |
| 0.1 |
0.3 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.1 |
0.8 |
GO:0045350 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.1 |
0.3 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.1 |
0.9 |
GO:0006200 |
obsolete ATP catabolic process(GO:0006200) |
| 0.1 |
0.4 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.1 |
0.6 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.3 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.1 |
1.2 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
4.2 |
GO:0016571 |
histone methylation(GO:0016571) |
| 0.1 |
0.5 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.3 |
GO:0003077 |
obsolete negative regulation of diuresis(GO:0003077) |
| 0.1 |
0.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.8 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
1.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
2.2 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.1 |
0.3 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
0.2 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
0.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.3 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
0.8 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.1 |
2.6 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.4 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.3 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.1 |
1.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.4 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.6 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
2.4 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.1 |
0.6 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.4 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.1 |
0.7 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.1 |
0.5 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.3 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
2.3 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
0.1 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.6 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.3 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.1 |
0.4 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.1 |
0.5 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
1.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
3.5 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.1 |
0.5 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
1.3 |
GO:0044819 |
mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
| 0.1 |
0.9 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.9 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.1 |
0.2 |
GO:0033673 |
negative regulation of kinase activity(GO:0033673) |
| 0.1 |
0.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
1.6 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
1.0 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
1.5 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
1.0 |
GO:0009057 |
macromolecule catabolic process(GO:0009057) |
| 0.1 |
0.3 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.1 |
0.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 |
0.9 |
GO:0009070 |
serine family amino acid biosynthetic process(GO:0009070) |
| 0.1 |
0.3 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.2 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
2.0 |
GO:0051051 |
negative regulation of transport(GO:0051051) |
| 0.1 |
0.4 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
1.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.1 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 |
1.1 |
GO:0010821 |
regulation of mitochondrion organization(GO:0010821) |
| 0.1 |
0.3 |
GO:0071883 |
adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
1.1 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.1 |
0.2 |
GO:0002890 |
negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
0.8 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.1 |
0.3 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
| 0.1 |
0.1 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.1 |
0.9 |
GO:1903078 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.1 |
0.3 |
GO:0009219 |
pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
| 0.1 |
0.6 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 |
0.4 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 |
2.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.2 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
1.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.3 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.5 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.7 |
GO:0000084 |
mitotic S phase(GO:0000084) |
| 0.1 |
0.4 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.6 |
GO:0045069 |
regulation of viral genome replication(GO:0045069) |
| 0.1 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.4 |
GO:0032608 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.3 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.1 |
0.8 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
0.6 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
0.2 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.1 |
2.4 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.1 |
0.3 |
GO:1904037 |
positive regulation of epithelial cell apoptotic process(GO:1904037) positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.2 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.4 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.1 |
0.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.8 |
GO:0051250 |
negative regulation of lymphocyte activation(GO:0051250) |
| 0.1 |
2.4 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.1 |
0.1 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.1 |
1.3 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.3 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
2.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.1 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.2 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
| 0.1 |
0.1 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.1 |
0.7 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.1 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.2 |
GO:0010430 |
ethanol catabolic process(GO:0006068) fatty acid omega-oxidation(GO:0010430) |
| 0.1 |
0.2 |
GO:0032928 |
regulation of superoxide anion generation(GO:0032928) negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.1 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 |
0.3 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 |
0.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.2 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.1 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.3 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) |
| 0.1 |
0.1 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
0.8 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.4 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.4 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.1 |
0.3 |
GO:0010243 |
response to organonitrogen compound(GO:0010243) response to nitrogen compound(GO:1901698) |
| 0.1 |
0.6 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.1 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
0.5 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
1.1 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
0.2 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 |
0.3 |
GO:0032754 |
positive regulation of interleukin-13 production(GO:0032736) positive regulation of interleukin-5 production(GO:0032754) |
| 0.1 |
1.2 |
GO:0050851 |
antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.1 |
0.1 |
GO:0035710 |
CD4-positive, alpha-beta T cell activation(GO:0035710) regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043370) positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
| 0.1 |
0.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.8 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.1 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 |
0.1 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.1 |
0.3 |
GO:0035630 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
0.7 |
GO:0019221 |
cytokine-mediated signaling pathway(GO:0019221) |
| 0.1 |
0.6 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
0.3 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
2.9 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.1 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.2 |
GO:0045885 |
obsolete positive regulation of survival gene product expression(GO:0045885) |
| 0.1 |
0.2 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.1 |
0.4 |
GO:0051262 |
protein tetramerization(GO:0051262) |
| 0.1 |
0.1 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.1 |
1.8 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
2.2 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.1 |
0.1 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) |
| 0.1 |
0.6 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.1 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
1.1 |
GO:0006469 |
negative regulation of protein kinase activity(GO:0006469) |
| 0.1 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.2 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.1 |
1.3 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.1 |
0.2 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.1 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.1 |
0.2 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.1 |
0.5 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 |
0.7 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.1 |
1.0 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.1 |
2.4 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.1 |
0.8 |
GO:0031623 |
receptor internalization(GO:0031623) |
| 0.1 |
0.2 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
3.2 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
1.2 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.2 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 0.1 |
0.2 |
GO:0001755 |
neural crest cell migration(GO:0001755) neural crest cell development(GO:0014032) neural crest cell differentiation(GO:0014033) |
| 0.1 |
1.1 |
GO:0007369 |
gastrulation(GO:0007369) |
| 0.1 |
0.1 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 |
0.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.1 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.1 |
0.3 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
0.1 |
GO:0030147 |
obsolete natriuresis(GO:0030147) |
| 0.1 |
0.3 |
GO:0045616 |
regulation of keratinocyte differentiation(GO:0045616) |
| 0.1 |
0.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.2 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine development(GO:0060998) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
| 0.1 |
0.1 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
1.7 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.8 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.1 |
0.3 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.1 |
0.4 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.2 |
GO:0071848 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) TNFSF11-mediated signaling pathway(GO:0071847) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.1 |
0.9 |
GO:0002286 |
T cell activation involved in immune response(GO:0002286) |
| 0.1 |
0.2 |
GO:2000242 |
negative regulation of reproductive process(GO:2000242) |
| 0.1 |
1.4 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.1 |
0.1 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.0 |
0.0 |
GO:0034776 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) response to histamine(GO:0034776) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of neurotransmitter transport(GO:0051590) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.0 |
0.7 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.7 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.0 |
0.6 |
GO:0042438 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.1 |
GO:0009135 |
purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
| 0.0 |
2.8 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.0 |
0.0 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.5 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.0 |
0.4 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) icosanoid biosynthetic process(GO:0046456) prostanoid biosynthetic process(GO:0046457) fatty acid derivative biosynthetic process(GO:1901570) |
| 0.0 |
1.2 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.1 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
0.3 |
GO:0009156 |
nucleoside monophosphate biosynthetic process(GO:0009124) ribonucleoside monophosphate biosynthetic process(GO:0009156) |
| 0.0 |
0.1 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.0 |
0.3 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.0 |
0.1 |
GO:0006081 |
cellular aldehyde metabolic process(GO:0006081) |
| 0.0 |
0.9 |
GO:0051453 |
regulation of intracellular pH(GO:0051453) |
| 0.0 |
0.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.0 |
0.2 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.0 |
0.3 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.1 |
GO:0015868 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.1 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.0 |
1.6 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
3.4 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.0 |
0.2 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.6 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.4 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.0 |
0.1 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
| 0.0 |
0.6 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.0 |
0.4 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.0 |
0.1 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.0 |
0.4 |
GO:0048892 |
sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
| 0.0 |
0.2 |
GO:0060025 |
regulation of germinal center formation(GO:0002634) regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.0 |
GO:0051320 |
S phase(GO:0051320) |
| 0.0 |
0.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.4 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.0 |
0.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.2 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.9 |
GO:0001525 |
angiogenesis(GO:0001525) |
| 0.0 |
0.1 |
GO:0052556 |
pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) |
| 0.0 |
0.1 |
GO:1901031 |
regulation of cellular response to oxidative stress(GO:1900407) regulation of response to reactive oxygen species(GO:1901031) regulation of response to oxidative stress(GO:1902882) |
| 0.0 |
1.1 |
GO:0007126 |
meiotic nuclear division(GO:0007126) |
| 0.0 |
0.3 |
GO:0051726 |
regulation of cell cycle(GO:0051726) |
| 0.0 |
0.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 |
0.2 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.7 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
0.2 |
GO:0007162 |
negative regulation of cell adhesion(GO:0007162) |
| 0.0 |
0.2 |
GO:0019827 |
stem cell population maintenance(GO:0019827) |
| 0.0 |
0.4 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.0 |
0.1 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.0 |
0.2 |
GO:0042977 |
activation of JAK2 kinase activity(GO:0042977) |
| 0.0 |
2.1 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 |
0.2 |
GO:0060487 |
lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.0 |
2.5 |
GO:0071824 |
protein-DNA complex subunit organization(GO:0071824) |
| 0.0 |
0.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
12.6 |
GO:0006412 |
translation(GO:0006412) |
| 0.0 |
1.1 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.2 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
0.5 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.4 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.1 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.0 |
0.2 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.0 |
0.3 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
0.1 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.0 |
0.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.0 |
0.2 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.0 |
0.2 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.0 |
0.1 |
GO:0050890 |
cognition(GO:0050890) |
| 0.0 |
0.4 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.1 |
GO:0046888 |
negative regulation of hormone secretion(GO:0046888) |
| 0.0 |
0.1 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
2.0 |
GO:0006325 |
chromatin organization(GO:0006325) |
| 0.0 |
0.2 |
GO:0006692 |
prostanoid metabolic process(GO:0006692) |
| 0.0 |
0.2 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.0 |
0.2 |
GO:0001660 |
fever generation(GO:0001660) |
| 0.0 |
0.0 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.1 |
GO:0030431 |
sleep(GO:0030431) |
| 0.0 |
0.3 |
GO:0048659 |
smooth muscle cell proliferation(GO:0048659) |
| 0.0 |
0.1 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.4 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.0 |
0.5 |
GO:0030282 |
bone mineralization(GO:0030282) |
| 0.0 |
0.2 |
GO:0043436 |
oxoacid metabolic process(GO:0043436) |
| 0.0 |
0.1 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 |
0.2 |
GO:0002639 |
positive regulation of immunoglobulin production(GO:0002639) |
| 0.0 |
0.1 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
0.3 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.0 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.0 |
0.2 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 0.0 |
0.6 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.1 |
GO:0042493 |
response to drug(GO:0042493) |
| 0.0 |
1.9 |
GO:0034339 |
obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
| 0.0 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.3 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.0 |
0.1 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.1 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) actin filament reorganization(GO:0090527) |
| 0.0 |
0.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.5 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.0 |
0.9 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.0 |
0.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.1 |
GO:0046676 |
negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.0 |
0.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.1 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.0 |
0.1 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.0 |
0.8 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.0 |
0.0 |
GO:0048469 |
cell maturation(GO:0048469) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.2 |
GO:0006893 |
Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
| 0.0 |
0.4 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
| 0.0 |
0.0 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 |
0.1 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.0 |
0.1 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.1 |
GO:0007128 |
meiotic prophase I(GO:0007128) |
| 0.0 |
0.1 |
GO:0046323 |
glucose import(GO:0046323) |
| 0.0 |
0.9 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 |
0.1 |
GO:0060193 |
positive regulation of lipase activity(GO:0060193) |
| 0.0 |
1.4 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.2 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.2 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 |
0.1 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.0 |
GO:0044060 |
regulation of endocrine process(GO:0044060) |
| 0.0 |
0.4 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.6 |
GO:0046068 |
cGMP metabolic process(GO:0046068) |
| 0.0 |
0.4 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 |
0.0 |
GO:0046146 |
tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.2 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.1 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 |
0.2 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.1 |
GO:0019059 |
obsolete initiation of viral infection(GO:0019059) |
| 0.0 |
0.2 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.0 |
3.6 |
GO:0016337 |
single organismal cell-cell adhesion(GO:0016337) |
| 0.0 |
0.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.1 |
GO:0070293 |
renal absorption(GO:0070293) |
| 0.0 |
0.3 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
26.5 |
GO:2001141 |
regulation of RNA biosynthetic process(GO:2001141) |
| 0.0 |
0.1 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.0 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.0 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.0 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 |
0.2 |
GO:0030099 |
myeloid cell differentiation(GO:0030099) |
| 0.0 |
0.1 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.3 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.0 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
0.0 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.0 |
0.2 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.1 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.2 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 |
0.2 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.1 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 |
0.0 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.0 |
0.1 |
GO:0043409 |
negative regulation of MAPK cascade(GO:0043409) |
| 0.0 |
0.1 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.0 |
0.1 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.0 |
0.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.2 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.0 |
0.1 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.1 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.4 |
GO:0006023 |
aminoglycan biosynthetic process(GO:0006023) |
| 0.0 |
0.0 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.9 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.2 |
GO:0042461 |
photoreceptor cell development(GO:0042461) |
| 0.0 |
0.0 |
GO:0043300 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of leukocyte degranulation(GO:0043300) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.0 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.0 |
GO:0048483 |
autonomic nervous system development(GO:0048483) |
| 0.0 |
0.1 |
GO:0034332 |
adherens junction organization(GO:0034332) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.0 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.0 |
0.1 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.0 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.0 |
GO:0021675 |
nerve development(GO:0021675) |
| 0.0 |
0.1 |
GO:0032438 |
melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.0 |
0.1 |
GO:0032880 |
regulation of protein localization(GO:0032880) |
| 0.0 |
0.4 |
GO:0006909 |
phagocytosis(GO:0006909) |
| 0.0 |
0.0 |
GO:0043650 |
glutamate biosynthetic process(GO:0006537) dicarboxylic acid biosynthetic process(GO:0043650) |
| 0.0 |
0.3 |
GO:0051925 |
obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
| 0.0 |
0.0 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.0 |
0.2 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.0 |
GO:0001552 |
ovarian follicle atresia(GO:0001552) |
| 0.0 |
0.2 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.0 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.0 |
0.1 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.0 |
0.1 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
